Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Bone Morphogenetic Protein Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence rate of sports-related injuries and spinal fusion procedure
5.1.1.2. Increasing awareness regarding the bone morphogenetic protein
5.1.1.3. Application of bone morphogenetic proteins in the treatment of clinical oral and maxillofacial osseous defects
5.1.2. Restraints
5.1.2.1. High cost of the procedure
5.1.3. Opportunities
5.1.3.1. Growing demand for minimally invasive medical procedures
5.1.3.2. Developing advancements in treatment lines for traumatic injuries
5.1.4. Challenges
5.1.4.1. Availability of the substitute treatment and products such as bone grafts and scaffolds
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization

6. Bone Morphogenetic Protein Market, by Type
6.1. Introduction
6.2. rhBMP-2
6.3. rhBMP-7

7. Bone Morphogenetic Protein Market, by Application
7.1. Introduction
7.2. Oral Maxillofacial
7.3. Reconstruction
7.4. Spinal fusion
7.5. Trauma

8. Americas Bone Morphogenetic Protein Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Bone Morphogenetic Protein Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Bone Morphogenetic Protein Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Akron Biotechnology, LLC
12.1.2. AlloSource, Inc.
12.1.3. Bioventus LLC
12.1.4. Cellumed Co. Ltd
12.1.5. Ember Therapeutics Inc.
12.1.6. Hangzhou Jiuyuan Gene Engineering Co .,Ltd
12.1.7. HiMedia Laboratories
12.1.8. Integra Lifesciences Corporation
12.1.9. Johnson & Johnson Services Inc.
12.1.10. Medtronic PLC
12.1.11. Merck KGaA
12.1.12. Olympus Corporation
12.1.13. Orthofix Holdings, Inc.
12.1.14. Pfizer, Inc.
12.1.15. Prospec-Tany Technogene Ltd.
12.1.16. R&D Systems, Inc.
12.1.17. ScienCell Research Laboratories, Inc.
12.1.18. Sino Biological Inc.
12.1.19. Smith & Nephew PLC
12.1.20. Stryker Corporation
12.1.21. Thermo Fisher Scientific, Inc
12.1.22. Xtant Medical Holdings, Inc
12.1.23. Zimmer Biomet Holdings, Inc.
12.2. Key Product Portfolio

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing



List of Figures

FIGURE 1. BONE MORPHOGENETIC PROTEIN MARKET RESEARCH PROCESS
FIGURE 2. BONE MORPHOGENETIC PROTEIN MARKET SIZE, 2022 VS 2030
FIGURE 3. BONE MORPHOGENETIC PROTEIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. BONE MORPHOGENETIC PROTEIN MARKET DYNAMICS
FIGURE 7. BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 8. BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 10. BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 12. AMERICAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 14. UNITED STATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. BONE MORPHOGENETIC PROTEIN MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 20. BONE MORPHOGENETIC PROTEIN MARKET SHARE, BY KEY PLAYER, 2022

List of Tables

TABLE 1. BONE MORPHOGENETIC PROTEIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2022
TABLE 3. BONE MORPHOGENETIC PROTEIN MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RHBMP-2, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RHBMP-7, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 9. BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY ORAL MAXILLOFACIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TRAUMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. AMERICAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 14. AMERICAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 16. ARGENTINA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 17. ARGENTINA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 18. BRAZIL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 19. BRAZIL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 20. CANADA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 21. CANADA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. MEXICO BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 23. MEXICO BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 27. ASIA-PACIFIC BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 28. ASIA-PACIFIC BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. ASIA-PACIFIC BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 30. AUSTRALIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. AUSTRALIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. CHINA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. CHINA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. INDIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. INDIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. INDONESIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37. INDONESIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. JAPAN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 39. JAPAN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. MALAYSIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41. MALAYSIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. PHILIPPINES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. PHILIPPINES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. SINGAPORE BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. SINGAPORE BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. SOUTH KOREA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. SOUTH KOREA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. TAIWAN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49. TAIWAN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. THAILAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. THAILAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. VIETNAM BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. VIETNAM BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. DENMARK BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. DENMARK BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. EGYPT BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. EGYPT BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. FINLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. FINLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. FRANCE BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. FRANCE BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. GERMANY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. GERMANY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. ISRAEL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. ISRAEL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. ITALY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. ITALY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. NETHERLANDS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. NETHERLANDS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. NIGERIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. NIGERIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. NORWAY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. NORWAY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. POLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. POLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. QATAR BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. QATAR BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. RUSSIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. SAUDI ARABIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. SAUDI ARABIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. SOUTH AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. SOUTH AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. SPAIN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. SPAIN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. SWEDEN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. SWEDEN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. SWITZERLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. SWITZERLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. TURKEY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. TURKEY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. UNITED ARAB EMIRATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. BONE MORPHOGENETIC PROTEIN MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 100. BONE MORPHOGENETIC PROTEIN MARKET SHARE, BY KEY PLAYER, 2022
TABLE 101. BONE MORPHOGENETIC PROTEIN MARKET LICENSE & PRICING